Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,982
archived clinical trials in
Endocrine

A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
Status: Enrolling
Updated:  9/25/2017
2446
mi
from 91732
Purchase, NY
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
2446
mi
from 91732
Purchase, NY
Click here to add this to my saved trials
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
Status: Enrolling
Updated:  9/25/2017
2560
mi
from 91732
Warwick, RI
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
2560
mi
from 91732
Warwick, RI
Click here to add this to my saved trials
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
Status: Enrolling
Updated:  9/25/2017
1763
mi
from 91732
Nashville, TN
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
1763
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
Status: Enrolling
Updated:  9/25/2017
1376
mi
from 91732
Webster, TX
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
1376
mi
from 91732
Webster, TX
Click here to add this to my saved trials
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
Status: Enrolling
Updated:  9/25/2017
2336
mi
from 91732
Norfolk, VA
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
2336
mi
from 91732
Norfolk, VA
Click here to add this to my saved trials
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
Status: Enrolling
Updated:  9/25/2017
2452
mi
from 91732
Garden City, NY
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
2452
mi
from 91732
Garden City, NY
Click here to add this to my saved trials
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
Status: Enrolling
Updated:  9/25/2017
2371
mi
from 91732
Bala-Cynwyd, PA
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
Status: Enrolling
Updated: 9/25/2017
2371
mi
from 91732
Bala-Cynwyd, PA
Click here to add this to my saved trials
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
Status: Enrolling
Updated:  9/25/2017
2187
mi
from 91732
Mount Pleasant, SC
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
2187
mi
from 91732
Mount Pleasant, SC
Click here to add this to my saved trials
Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids
Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids (HEARTS)
Status: Enrolling
Updated:  9/26/2017
2578
mi
from 91732
Boston, MA
Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids
Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids (HEARTS)
Status: Enrolling
Updated: 9/26/2017
Beth Israel Deaconess Medical Center
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids
Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids (HEARTS)
Status: Enrolling
Updated:  9/26/2017
2577
mi
from 91732
Milton, MA
Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids
Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids (HEARTS)
Status: Enrolling
Updated: 9/26/2017
South Shore Medical Group
2577
mi
from 91732
Milton, MA
Click here to add this to my saved trials
Pioglitazone in Thyroid Cancers
Phase 2 Study of Pioglitazone in Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene
Status: Enrolling
Updated:  9/27/2017
820
mi
from 91732
Aurora, CO
Pioglitazone in Thyroid Cancers
Phase 2 Study of Pioglitazone in Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene
Status: Enrolling
Updated: 9/27/2017
University of Colorado
820
mi
from 91732
Aurora, CO
Click here to add this to my saved trials
Pioglitazone in Thyroid Cancers
Phase 2 Study of Pioglitazone in Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene
Status: Enrolling
Updated:  9/27/2017
1932
mi
from 91732
Ann Arbor, MI
Pioglitazone in Thyroid Cancers
Phase 2 Study of Pioglitazone in Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene
Status: Enrolling
Updated: 9/27/2017
University of Michigan
1932
mi
from 91732
Ann Arbor, MI
Click here to add this to my saved trials
Pioglitazone in Thyroid Cancers
Phase 2 Study of Pioglitazone in Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene
Status: Enrolling
Updated:  9/27/2017
2373
mi
from 91732
Philadelphia, PA
Pioglitazone in Thyroid Cancers
Phase 2 Study of Pioglitazone in Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene
Status: Enrolling
Updated: 9/27/2017
Univ of Pennsylvania
2373
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
Pioglitazone in Thyroid Cancers
Phase 2 Study of Pioglitazone in Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene
Status: Enrolling
Updated:  9/27/2017
1357
mi
from 91732
Houston, TX
Pioglitazone in Thyroid Cancers
Phase 2 Study of Pioglitazone in Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene
Status: Enrolling
Updated: 9/27/2017
University of Texas M.D. Anderson Cancer Center
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Comparison of Neutral Protamine Hagedorn (NPH) and Lantus Based Insulin Regimen in the Management of Hypoglycemia in the Hospitalized Patients in Noncritical Care Setting
Comparison of Neutral Protamine Hagedorn (NPH) and Lantus Based Insulin Regimen in the Management of Hypoglycemia in the Hospitalized Patients in Noncritical Care Setting
Status: Enrolling
Updated:  9/27/2017
48
mi
from 91732
Moreno Valley, CA
Comparison of Neutral Protamine Hagedorn (NPH) and Lantus Based Insulin Regimen in the Management of Hypoglycemia in the Hospitalized Patients in Noncritical Care Setting
Comparison of Neutral Protamine Hagedorn (NPH) and Lantus Based Insulin Regimen in the Management of Hypoglycemia in the Hospitalized Patients in Noncritical Care Setting
Status: Enrolling
Updated: 9/27/2017
Riverside County Regional Medical Center
48
mi
from 91732
Moreno Valley, CA
Click here to add this to my saved trials
Effects of Growth Hormone Releasing Hormone in HIV
Effects of Growth Hormone Releasing Hormone on Fat Redistribution, Cardiovascular Indices, and Growth Hormone Secretion in HIV Lipodystrophy
Status: Enrolling
Updated:  9/28/2017
2578
mi
from 91732
Boston, MA
Effects of Growth Hormone Releasing Hormone in HIV
Effects of Growth Hormone Releasing Hormone on Fat Redistribution, Cardiovascular Indices, and Growth Hormone Secretion in HIV Lipodystrophy
Status: Enrolling
Updated: 9/28/2017
Massachusetts General Hospital
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
The Health Effects of Blueberry Anthocyanins in Metabolic Syndrome (the CIRCLES-study)
The Effects of Blueberry Anthocyanins on Insulin Resistance and Vascular, Lung and Cognitive Function in a Population With Metabolic Syndrome.
Status: Enrolling
Updated:  9/28/2017
2576
mi
from 91732
Boston, MA
The Health Effects of Blueberry Anthocyanins in Metabolic Syndrome (the CIRCLES-study)
The Effects of Blueberry Anthocyanins on Insulin Resistance and Vascular, Lung and Cognitive Function in a Population With Metabolic Syndrome.
Status: Enrolling
Updated: 9/28/2017
Harvard School of Public Health
2576
mi
from 91732
Boston, MA
Click here to add this to my saved trials
The Health Effects of Blueberry Anthocyanins in Metabolic Syndrome (the CIRCLES-study)
The Effects of Blueberry Anthocyanins on Insulin Resistance and Vascular, Lung and Cognitive Function in a Population With Metabolic Syndrome.
Status: Enrolling
Updated:  9/28/2017
5409
mi
from 91732
Cambridge,
The Health Effects of Blueberry Anthocyanins in Metabolic Syndrome (the CIRCLES-study)
The Effects of Blueberry Anthocyanins on Insulin Resistance and Vascular, Lung and Cognitive Function in a Population With Metabolic Syndrome.
Status: Enrolling
Updated: 9/28/2017
Addenbrooke's hospital
5409
mi
from 91732
Cambridge,
Click here to add this to my saved trials
Prospective Study of Undiagnosed Celiac Disease
Epidemiology of Celiac Disease: A Prospective Study of Undiagnosed Celiac Disease in the Community
Status: Enrolling
Updated:  9/28/2017
1524
mi
from 91732
Rochester, MN
Prospective Study of Undiagnosed Celiac Disease
Epidemiology of Celiac Disease: A Prospective Study of Undiagnosed Celiac Disease in the Community
Status: Enrolling
Updated: 9/28/2017
Mayo Clinic Rochester
1524
mi
from 91732
Rochester, MN
Click here to add this to my saved trials
Testosterone Replacement Therapy in Chronic Spinal Cord Injury
Testosterone Replacement Therapy in Chronic Spinal Cord Injury
Status: Enrolling
Updated:  9/29/2017
2419
mi
from 91732
West Orange, NJ
Testosterone Replacement Therapy in Chronic Spinal Cord Injury
Testosterone Replacement Therapy in Chronic Spinal Cord Injury
Status: Enrolling
Updated: 9/29/2017
Kessler Institute for Rehabilitation
2419
mi
from 91732
West Orange, NJ
Click here to add this to my saved trials
Testosterone Replacement Therapy in Chronic Spinal Cord Injury
Testosterone Replacement Therapy in Chronic Spinal Cord Injury
Status: Enrolling
Updated:  9/29/2017
2437
mi
from 91732
The Bronx, NY
Testosterone Replacement Therapy in Chronic Spinal Cord Injury
Testosterone Replacement Therapy in Chronic Spinal Cord Injury
Status: Enrolling
Updated: 9/29/2017
James J. Peters VA Medical Center
2437
mi
from 91732
The Bronx, NY
Click here to add this to my saved trials
A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid Syndrome
A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid Syndrome (RITAPS)
Status: Enrolling
Updated:  10/2/2017
2435
mi
from 91732
New York, NY
A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid Syndrome
A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid Syndrome (RITAPS)
Status: Enrolling
Updated: 10/2/2017
Barbara Volcker Center for Women and Rheumatic Disease, Hospital for Special Surgery
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials
The VA Diabetes Trial Follow-up Study (VADT-FS)
CSP #465FS - VA Diabetes Trial Long Term Follow-up Study
Status: Enrolling
Updated:  10/2/2017
mi
from 91732
Phoenix, AZ
The VA Diabetes Trial Follow-up Study (VADT-FS)
CSP #465FS - VA Diabetes Trial Long Term Follow-up Study
Status: Enrolling
Updated: 10/2/2017
Phoenix VA Health Care System, Phoenix, AZ
mi
from 91732
Phoenix, AZ
Click here to add this to my saved trials
The VA Diabetes Trial Follow-up Study (VADT-FS)
CSP #465FS - VA Diabetes Trial Long Term Follow-up Study
Status: Enrolling
Updated:  10/2/2017
2319
mi
from 91732
Miami, FL
The VA Diabetes Trial Follow-up Study (VADT-FS)
CSP #465FS - VA Diabetes Trial Long Term Follow-up Study
Status: Enrolling
Updated: 10/2/2017
Miami VA Healthcare System, Miami, FL
2319
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Etanercept in Kawasaki Disease
A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease
Status: Enrolling
Updated:  10/3/2017
mi
from 91732
New Hyde Park, NY
Etanercept in Kawasaki Disease
A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease
Status: Enrolling
Updated: 10/3/2017
Feinstein Institute for Medical Rsearch
mi
from 91732
New Hyde Park, NY
Click here to add this to my saved trials
Etanercept in Kawasaki Disease
A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease
Status: Enrolling
Updated:  10/3/2017
2432
mi
from 91732
New York, NY
Etanercept in Kawasaki Disease
A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease
Status: Enrolling
Updated: 10/3/2017
Columbia University Medical Center
2432
mi
from 91732
New York, NY
Click here to add this to my saved trials
Etanercept in Kawasaki Disease
A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease
Status: Enrolling
Updated:  10/3/2017
1357
mi
from 91732
Houston, TX
Etanercept in Kawasaki Disease
A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease
Status: Enrolling
Updated: 10/3/2017
Texas Children's Hospital
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Etanercept in Kawasaki Disease
A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease
Status: Enrolling
Updated:  10/3/2017
573
mi
from 91732
Salt Lake City, UT
Etanercept in Kawasaki Disease
A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease
Status: Enrolling
Updated: 10/3/2017
Primary Children's Medical Center
573
mi
from 91732
Salt Lake City, UT
Click here to add this to my saved trials
Etanercept in Kawasaki Disease
A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease
Status: Enrolling
Updated:  10/3/2017
964
mi
from 91732
Seattle, WA
Etanercept in Kawasaki Disease
A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease
Status: Enrolling
Updated: 10/3/2017
Seattle Children's Hospital
964
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
Etanercept in Kawasaki Disease
A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease
Status: Enrolling
Updated:  10/3/2017
1722
mi
from 91732
Milwaukee, WI
Etanercept in Kawasaki Disease
A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease
Status: Enrolling
Updated: 10/3/2017
Children's Hospital of Wisconsin
1722
mi
from 91732
Milwaukee, WI
Click here to add this to my saved trials
Etanercept in Kawasaki Disease
A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease
Status: Enrolling
Updated:  10/3/2017
2452
mi
from 91732
Montreal,
Etanercept in Kawasaki Disease
A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease
Status: Enrolling
Updated: 10/3/2017
Sainte-Justine Hospital
2452
mi
from 91732
Montreal,
Click here to add this to my saved trials
Etanercept in Kawasaki Disease
A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease
Status: Enrolling
Updated:  10/3/2017
2439
mi
from 91732
The Bronx, NY
Etanercept in Kawasaki Disease
A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease
Status: Enrolling
Updated: 10/3/2017
Montefiore Medical Center
2439
mi
from 91732
The Bronx, NY
Click here to add this to my saved trials
Insulin Resistance in Patients With Major Depression
Insulin Resistance in Patients With Major Depression
Status: Enrolling
Updated:  10/3/2017
328
mi
from 91732
Stanford, CA
Insulin Resistance in Patients With Major Depression
Insulin Resistance in Patients With Major Depression
Status: Enrolling
Updated: 10/3/2017
Stanford University School of Medicine
328
mi
from 91732
Stanford, CA
Click here to add this to my saved trials
Pharmacology of Exenatide in Pediatric Sepsis
Phase 1-2 Study of the Pharmacology of Exenatide in Pediatric Sepsis
Status: Enrolling
Updated:  10/3/2017
964
mi
from 91732
Seattle, WA
Pharmacology of Exenatide in Pediatric Sepsis
Phase 1-2 Study of the Pharmacology of Exenatide in Pediatric Sepsis
Status: Enrolling
Updated: 10/3/2017
Seattle Children's Hospital
964
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic Syndrome
Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic Syndrome
Status: Enrolling
Updated:  10/4/2017
2578
mi
from 91732
Boston, MA
Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic Syndrome
Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic Syndrome
Status: Enrolling
Updated: 10/4/2017
Mass General Hospital
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Ovarian Follicle Function in Patients With Primary Ovarian Failure
Ovarian Follicle Function in Patients With Primary Ovarian Insufficiency
Status: Enrolling
Updated:  10/5/2017
2277
mi
from 91732
Bethesda, MD
Ovarian Follicle Function in Patients With Primary Ovarian Failure
Ovarian Follicle Function in Patients With Primary Ovarian Insufficiency
Status: Enrolling
Updated: 10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
2277
mi
from 91732
Bethesda, MD
Click here to add this to my saved trials
Endocrine Studies in Health and Disease
Endocrine Studies in Health and Disease
Status: Enrolling
Updated:  10/5/2017
2277
mi
from 91732
Bethesda, MD
Endocrine Studies in Health and Disease
Endocrine Studies in Health and Disease
Status: Enrolling
Updated: 10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
2277
mi
from 91732
Bethesda, MD
Click here to add this to my saved trials
Studies of Children With Metabolic and Other Genetic Disorders
Studies of Pediatric Patients With Metabolic or Other Genetic Disorders
Status: Enrolling
Updated:  10/5/2017
2277
mi
from 91732
Bethesda, MD
Studies of Children With Metabolic and Other Genetic Disorders
Studies of Pediatric Patients With Metabolic or Other Genetic Disorders
Status: Enrolling
Updated: 10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
2277
mi
from 91732
Bethesda, MD
Click here to add this to my saved trials
Pharmacogenomic Response to Thyrotropin-Releasing Hormone Stimulation in Healthy Volunteers: The Influence of a Common Type 2 Deiodinase Genetic Polymorphism on Serum T3
Pharmacogenomic Response to Thyrotropin-Releasing Hormone Stimulation in Healthy Volunteers:The Influence of a Common Type 2 Deiodinase Genetic Polymorphism on Serum T3
Status: Enrolling
Updated:  10/5/2017
2277
mi
from 91732
Bethesda, MD
Pharmacogenomic Response to Thyrotropin-Releasing Hormone Stimulation in Healthy Volunteers: The Influence of a Common Type 2 Deiodinase Genetic Polymorphism on Serum T3
Pharmacogenomic Response to Thyrotropin-Releasing Hormone Stimulation in Healthy Volunteers:The Influence of a Common Type 2 Deiodinase Genetic Polymorphism on Serum T3
Status: Enrolling
Updated: 10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
2277
mi
from 91732
Bethesda, MD
Click here to add this to my saved trials
Radioactive Iodide Therapy for Pediatric Graves' Disease
Radioactive Iodide Therapy for Pediatric Graves' Disease
Status: Enrolling
Updated:  10/5/2017
2104
mi
from 91732
Gainesville, FL
Radioactive Iodide Therapy for Pediatric Graves' Disease
Radioactive Iodide Therapy for Pediatric Graves' Disease
Status: Enrolling
Updated: 10/5/2017
University of Florida
2104
mi
from 91732
Gainesville, FL
Click here to add this to my saved trials
Radioactive Iodide Therapy for Pediatric Graves' Disease
Radioactive Iodide Therapy for Pediatric Graves' Disease
Status: Enrolling
Updated:  10/5/2017
1357
mi
from 91732
Houston, TX
Radioactive Iodide Therapy for Pediatric Graves' Disease
Radioactive Iodide Therapy for Pediatric Graves' Disease
Status: Enrolling
Updated: 10/5/2017
Texas Children's Hospital
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Rituximab for Autoimmune Retinopathy
Rituximab for Autoimmune Retinopathy
Status: Enrolling
Updated:  10/5/2017
2277
mi
from 91732
Bethesda, MD
Rituximab for Autoimmune Retinopathy
Rituximab for Autoimmune Retinopathy
Status: Enrolling
Updated: 10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
2277
mi
from 91732
Bethesda, MD
Click here to add this to my saved trials
Jugular Vein Sampling for Hormone Levels for the Diagnosis of Cushing Syndrome
Internal Jugular Vein Sampling for ACTH Levels for the Differential Diagnosis of Cushing Syndrome
Status: Enrolling
Updated:  10/5/2017
2277
mi
from 91732
Bethesda, MD
Jugular Vein Sampling for Hormone Levels for the Diagnosis of Cushing Syndrome
Internal Jugular Vein Sampling for ACTH Levels for the Differential Diagnosis of Cushing Syndrome
Status: Enrolling
Updated: 10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
2277
mi
from 91732
Bethesda, MD
Click here to add this to my saved trials
Targeted Levothyroxine Dosing in Infants With Congenital Hypothyroidism
Targeted Levothyroxine Dosing in Infants With Congenital Hypothyroidism
Status: Enrolling
Updated:  10/6/2017
1793
mi
from 91732
Indianapolis, IN
Targeted Levothyroxine Dosing in Infants With Congenital Hypothyroidism
Targeted Levothyroxine Dosing in Infants With Congenital Hypothyroidism
Status: Enrolling
Updated: 10/6/2017
Riley Hospital for Children
1793
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
343
mi
from 91732
Phoenix, AZ
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Pediatric Endocrinology of Phoenix
343
mi
from 91732
Phoenix, AZ
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
211
mi
from 91732
Clovis, CA
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Sierra Medical Research
211
mi
from 91732
Clovis, CA
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
15
mi
from 91732
Los Angeles, CA
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Childrens Hospital Los Angeles
15
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
101
mi
from 91732
San Diego, CA
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Rady Children's Hospital - San Diego
101
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
820
mi
from 91732
Centennial, CO
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
The Rocky Mountain Pediatric Endocrinology
820
mi
from 91732
Centennial, CO
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
2130
mi
from 91732
Jacksonville, FL
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Nemours Children's Clinic
2130
mi
from 91732
Jacksonville, FL
Click here to add this to my saved trials